Spots Global Cancer Trial Database for American Ginseng in Treating Patients With Cancer-Related Fatigue

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: American Ginseng in Treating Patients With Cancer-Related Fatigue

Official Title: The Use of American Ginseng (Panax Quinquefolius) to Improve Cancer-Related Fatigue: A Randomized, Double-Blind, Dose-Finding, Placebo-Controlled Study

Study ID: NCT00182780

Conditions

Fatigue

Unspecified Adult Solid Tumor, Protocol Specific

Interventions

American ginseng

Placebo

Study Description

Brief Summary: RATIONALE: American ginseng may help relieve cancer-related fatigue. PURPOSE: This clinical trial is studying how well American ginseng works in treating patients with cancer-related fatigue.

Detailed Description: OBJECTIVES: Primary * Compare the efficacy of American ginseng, administered at 3 different doses, vs placebo in patients with cancer-related fatigue. Secondary * Determine the toxic effects and tolerability of American ginseng in these patients. * Determine the impact of American ginseng on quality of life-related variables (e.g., sleep, vitality, and quality of life domains) in these patients. OUTLINE: This is a randomized, double-blind, placebo-controlled, multicenter study. Patients are stratified according to disease stage (I or II vs III or IV vs unknown), gender (male vs female), baseline fatigue score (4-7 vs 8-10), concurrent chemotherapy (yes vs no), and concurrent radiotherapy (yes vs no). Patients are randomized to 1 of 4 treatment arms.